jRCT2031240352进行中（未招募）不适用
Phase 3 a long-term administration study of NTa53 in Patients with Allergic Conjunctivitis
试验速览
- 阶段
- 不适用
- 状态
- 进行中（未招募）
- 入组人数
- 120
- 主要终点
- Safety
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
- 分配方式
- Non-randomized Controlled Trial
- 干预模型
- Single Assignment
- 主要目的
- Treatment Purpose
- 盲法
- Open(masking Not Used)
入排标准
- 年龄范围
- 7age old over 至 No limit（—）
- 性别
- All
入选标准
- •Provided signed, written informed consent.
- •Has a positive result from a Type I allergy test.
排除标准
- •Eye disease other than allergic conjunctivitis is present and requires treatment.
- •Other protocol-specified exclusion criteria may apply.
结局指标
主要结局
Safety
Adverse Events, Ophthalmologic Examination and Clinical Examination
Efficacy
Subjective Ocular Symptom Score, Objective Ocular Findings Score, Quality Of Life Survey
次要结局
未报告次要终点
研究者
相似试验
未知
3 期
A phase III study of TAK-536 (long-term use study)Essential hypertensionJPRN-jRCT2080220837Takeda Pharmaceutical Company Limited360
已完成
3 期
ong Term Follow-up Phase III Clinical Trial of TAP-144-SR (3M) in Patients with Spinal and Bulbar Muscular Atrophy (SBMA)Spinal and Bulbar Muscular Atrophy (SBMA)JPRN-UMIN000001010Department of Neurology, Nagoya University School of Medicine152
招募中
不适用
A phase 3 long-term treatment study to evaluate the safety and efficacy of AKP-022 in patients with uterine fibroids (LUNA2)jRCT2031240570ASKA Pharmaceutical Co., Ltd.350
进行中（未招募）
不适用
A phase 3, open-label 96-week extension study of the safety of apricitabine in treatment-experienced HIV-1 infected patients who have completed protocol AVX-301 or AVX-302 or who have met the criteria for open-label access to ATC because ofvirologic failure/lack of response. - AVX-303HIV-1MedDRA version: 9.1Level: LLTClassification code 10064446Term: HIV infection WHO clinical stage IEUCTR2008-001486-28-FRAvexa Limited1,866
进行中（未招募）
不适用
A phase 3, open-label 96-week extension study of the safety of apricitabine in treatment-experienced HIV-1 infected patients who have completed protocol AVX-301 or AVX-302 or who have met the criteria for open-label access to ATC because ofvirologic failure/lack of response. - 303HIV-1MedDRA version: 9.1Level: LLTClassification code 10064446Term: HIV infection WHO clinical stage IEUCTR2008-001486-28-BEAvexa Limited1,866